Fortive CORP 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NYSE
Fortive Corporation announced its second quarter 2026 financial results, showcasing a notable increase in sales and operating profit driven by strong performance in its Intelligent Operating Solutions and Advanced Healthcare Solutions segments.
NYSE
Fortive Corporation announced its first quarter 2026 financial results, with total sales increasing by 7.7% year-over-year to $1,069.4 million, driven by core revenue growth and improved operating profit margins.
NYSE
Fortive reports a 2.3% increase in Q3 2025 total sales from continuing operations, driven by favorable pricing and strategic debt reduction following the Ralliant spin-off.
NYSE
Fortive Corporation reported a decrease in sales and net earnings for the second quarter and year-to-date periods of 2025, impacted by volume declines, higher costs, and significant expenses related to the Precision Technologies segment separation.
NYSE
Fortive Corporation's Q1 2025 sales decreased by 3.3%, with a CFO transition announced and progress reported on the planned spin-off of the Precision Technologies segment.
NYSE
Fortive Corporation announced its Q3 2024 financial results and its plan to separate into two independent publicly traded companies by the fourth quarter of 2025.
NYSE
Fortive Corporation's Q2 2024 results show a slight revenue increase, impacted by strategic divestitures and acquisitions, with varying performance across its business segments.
NYSE
Fortive Corporation's first quarter 2024 results show a 4.4% increase in sales, fueled by core revenue growth and strategic acquisitions, despite some currency headwinds.